Steroid eye drops as add-on therapy for bacterial corneal ulcers
Part of Eyes & vision, Infections clinical trials.
This study is testing a steroid eye drop (fluorometholone) as an add-on to standard antibiotic treatment for bacterial corneal ulcers. The goal is to see if adding the steroid helps reduce inflammation and improves healing compared to antibiotics alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a bacterial corneal ulcer (an open sore on the clear front part of your eye) confirmed by a doctor.
- The ulcer must be mild or moderate in size and depth—it can't be too large or deep.
- You must have had a culture or PCR test from your eye to check for bacteria (this is usually done before starting antibiotics).
- You must have already used antibiotic eye drops for at least 2 to 4 days before starting the study.
- You must not have conditions like herpes, fungal, or amoeba eye infections, or a perforated cornea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests if an antibiotic injection directly into the cornea can help when standard eye drops are not working for a stubborn bacterial eye infection.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
Hear when a new Keratitis Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.